The effect of rebamipide on Helicobacter pylori extract-mediated changes of gene expression in gastric epithelial cells

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 18, Issue 1, 2003, Pages 63-75

  Yoshida, N ^a   Ishikawa, T ^a   Ichiishi, E ^a   Yoshida, Y ^b   Hanashiro, K ^b   Kuchide, M ^a   Uchiyama, K ^a   Kokura, S ^a   Ichikawa, H ^a   Naito, Y ^a   Yamamura, Y ^c   Okanoue, T ^a   Yoshikawa, T ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Health and Longevity Research Center   (Japan)

^c MEIJI UNIVERSITY OF INTEGRATIVE MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CHEMOKINE; CYTOKINE; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 2; MACROPHAGE INFLAMMATORY PROTEIN 2BETA; RANTES; REACTIVE OXYGEN METABOLITE; REBAMIPIDE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ALANINE; ANTIULCER AGENT; DRUG DERIVATIVE; FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; MONOKINE; QUINOLONE DERIVATIVE;

BACTERIAL STRAIN; CANCER CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA MICROARRAY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION; GENETIC CODE; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH EPITHELIUM; UNINDEXED SEQUENCE; UPREGULATION; ARTICLE; CELL CULTURE; EPITHELIUM CELL; GENETICS; METABOLISM; MICROBIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH MUCOSA; STOMACH TUMOR;

ALANINE; ANTI-ULCER AGENTS; DOWN-REGULATION; EPITHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; GASTRIC MUCOSA; GENE EXPRESSION; HELICOBACTER PYLORI; HUMANS; MONOKINES; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; QUINOLONES; RANTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0042284511     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.18.s1.7.x     Document Type: Conference Paper

References (35)

1. Graham DY. Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989; 96: 615-25.
2. Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994; 89: S116-28.
3. Correa P, Fox J, Fontham E, et al. Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer 1990; 66(12): 2569-74.
4. Sharma SA, Tumuru MKR, Miller GG, et al. Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J Immun 1995; 65: 2401-7.
5. Aihara M, Tsuchimoto D, Takizawa H, et al. Mechanisms involved in Helicobacter pylori-induced interleukin 8 production by gastric cancer cell line. MKN45. Infect Immun 1997; 65: 3218-24.
6. Meyer-Ter-Vehn T, Covacci A, Kist M, et al. Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the protooncogenes c-fos and c-jun. J Biol Chem 2000; 275: 16064-72.
7. DeRisi J, Penland L, Brown PO, et al. Use of a cDNA microarray to analyse gene expression pattern in human cancer. Nat Genet 1996; 14: 457-60.
8. Chiou CC, Chan CC, Sheu DL, et al. Helicobacter pylori infection induced alteration of gene expression in human gastric cells. Gut 2001; 48: 598-604.
9. Maeda S, Otsuka M, Hirata Y, et al. cDNA microarray analysis of Helicobacter pylori-mediated alteration of gene expression in gastric cancer cells. Biochem Biophys Res Commun 2001; 284: 443-9.
10. Cox JM, Clayton CL, Tomita T, et al. cDNA array analysis of cag pathogenicity island-associated Helicobacter pylori epithelial cell response genes. Infect Immun 2001; 69: 6970-80.
11. Bach S, Makristathis A, Rotter M, et al. Gene expression profiling in AGS cells stimulated with Helicobacter pylori isogenic strains (cagA positive or cagA negative). Infect Immun 2002; 70: 988-92.
12. Sepulveda AR, Tao H, Carloni E, et al. Screening of gene expression profiles in gastric epithelial cells induced by Helicobacter pylori using microarray analysis. Aliment Pharmacol Ther 2002; 16(Suppl.): 145-57.
13. Masamune A, Yoshida M, Sakai Y, et al. Rebamipide inhibits ceramide-induced interleukin-8 production in Kato III human gastric cancer cells. J Pharmacol Exp Ther 2001; 298: 485-92.
14. Grilli M, Chin JJS, Lenardo MJ. NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol 1993; 143: 1-62.
15. Yoshida N, Granger DN, Evans DJ, et al. Mechanisms involved in Helicobacter pylori-induced inflammation. Gastroenterology 1993; 105: 1431-40.
16. Yoshida N, Kassai K, Fujita N, et al. Helicobacter pylori water extract induces upregulation of adhesion molecules on endothelial cells. Dig Dis Sci 2003; in press.
17. Yoshida N, Yoshikawa T, Iinuma S, et al. Rebamipide protects against activation of neutrophils by Helicobacter pylori. Dig Dis Sci 1996; 41: 1139-44.
18. Fandriks L, von Bothmer C, Johansson B, et al. Water extract of Helicobacter pylori inhibits duodenal mucosal alkaline secretion in anesthetized rats. Gastroenterology 1997; 113: 1570-5.
19. Beales I, Blaser MJ, Srinivasan S, et al. Effect of Helicobacter pylori products and recombinant cytokines on gastrin release from cultured canine G cells. Gastroenterology 1997; 113: 465-71.
20. Kassai K, Yoshikawa T, Yoshida N, et al. Helicobacter pylori water extract induces interleukin-8 production by gastric epithelial cells. Dig Dis Sci 1999; 44: 237-42.
21. Bhattacharyya A, Pathak S, Datta S, et al. Mitogen-activated protein kinase and NF-kappaB regulate Helicobacter pylori-mediated interleukin-8 release from macrophages. Biochem J 2002; 15: 121-9.
22. Kurosawa A, Miwa H, Hirose M, et al. Inhibition of cell proliferation and induction of apoptosis by Helicobacter pylori through increased phosphorylated p53, p21 and Bax expression in endothelial cells. L Medical Microbiol 2002; 51: 385-91.
23. Hono H. Establishment of culture cell lines of human stomach cancer: origin and their morphological characteristics. Niigata Med J 1977; 91: 737-52.
24. Naito Y, Yoshikawa T, Iinuma S, et al. Local gastric and serum concentration of rebamipide following oral administration to patients with chronic gastritis. Arzneim-Forsch/Drug Res 1996; 46: 698-700.
25. Wodicka L, Dong H, Mittmann M, et al. Genome-wide expression monitoring in Saccharomyces cerevisiae. Nat Biotechnol 1997; 15: 1359-67.
26. Wormstone IM, Del Rio-Tsonis K, McMahon G, et al. FGF. An autocrine regulator of human lens cell growth independent of added stimuli. Invest Ophthalmol Vis Sci 2001; 42: 1305-11.
27. Yamaoka Y, Kita M, Kodama T, et al. Chemokines in the gastric mucosa in Helicobacter pylori infection. Gut 1998; 42: 609-17.
28. Oka M, Hirose K, Iizuka N, et al. Cytokine mRNA expression patterns in human esophageal cancer cell lines. J Interferon Cytokine Res 1995; 15: 1005-9.
29. Isaacson PG. Gastric MALT lymphoma: from concept to cure. Ann Oncol 1999; 10: 637-45.
30. Ogino K, Hobara T, Ishiyama H, et al. Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on dimethyl dithiocarbamate-induced antral gastric ulcers in rats. Eur J Pharmacol 1992; 212: 9-13.
31. Suzuki M, Miura S, Mori M, et al. Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants. Gut 1994; 35: 1375-8.
32. Aihara M, Azuma A, Takizawa H, et al. Molecular analysis of suppression of interleukin-8 production by rebamipide in Helicobacter pylori-stimulated gastric cancer cell lines. Dig Dis Sci 1998; 43: S174-80.
33. Suzuki H, Mori M, Kai A, et al. Effect of rebamipide on H. pylori-associated mucosal injury in Mongolian gerbils. Dig Dis Sci 1998; 43: S181-7.
34. Yi HK, Hwang PHY, Ang DH, et al. Expression of the insulin-like growth factors (IGFs) and the IGF-binding proteins (IGFBPs) in human gastric cancer cells. Eur J Cancer 2001; 37: 2257-63.
35. Jones MK, Tomikawa M, Mohajer B, et al. Gastrointestinal mucosal regeneration: role of growth factors. Front Biosci 1999; 4: 303-9.